New York, NY -- (SBWIRE) -- 01/13/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), VIVUS, Inc (NASDAQ:VVUS), Emerald Oil Inc (NYSEMKT:EOX), CombiMatrix Corporation (NASDAQ:CBMX)
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) showed a volume of 1.31 million shares by the end of last trade whereas the average volume of the stock remained 3.09 million shares. The stock opened the session at $3.15 but then moved to $3.24. At that price, the stock showed a positive performance of 3.18%. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream,
Will AVNR Continue To Move Higher? Find Out Here
VIVUS, Inc (NASDAQ:VVUS) opened the session at $9.11 and closed the session at $9.18. The stock showed a positive performance of 1.10% in previous trading session. Traded with volume of 1.30 million shares in the prior session and the average volume of the stock remained 1.55 million shares. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese),
For How Long VVUS will fight for Profitability? Read This Trend Analysis report
Emerald Oil Inc (NYSEMKT:EOX) opened the session at $7.37 and closed the session at $7.48 The stock showed a positive performance of 6.10% in previous trading session. Traded with volume of 1.30 million shares in the prior session and the average volume of the stock remained 671,527.00 shares. The beta of the stock remained 0.97. Emerald Oil, Inc. (Emerald) is an independent oil and natural gas exploration and production company. It focuses on developing oil wells in the Williston Basin of North Dakota and Montana primarily targeting the Bakken and three forks shale oil formations. It controls approximately 35,000 net acres in the Williston Basin. In addition to its Williston Basin position, Emerald holds positions in the Rocky Mountain oil and natural gas plays. It has approximately 14,500 net acres in the Sand Wash Basin in northwest Colorado prospective for oil in the Niobrara formation.
Why Should Investors Buy EOX After The Recent Gain? Just Go Here and Find Out
CombiMatrix Corporation (NASDAQ:CBMX) the stock advanced 3.19% and finished the session at $2.91. Traded with volume of 1.30 million shares in the prior session and the average volume of the stock remained 973,867.00 shares. The beta of the stock remained -0.15. CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc. located in Irvine, California. The Company operates as a diagnostics reference laboratory, providing DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics.
Will CBMX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)